RecruitingNot ApplicableNCT06638099

Increasing CGM Use Among Patients With T2D

Increasing Use of Continuous Glucose Monitors Among Patients With Type 2 Diabetes


Sponsor

San Diego State University

Enrollment

318 participants

Start Date

Nov 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Study Overview: This interventional study aims to assess whether training healthcare professionals (HCPs) increases the number of continuous glucose monitor (CGM) prescriptions for patients with Type 2 Diabetes in a Federally Qualified Health Center serving a predominantly Hispanic/Latino population. Research Questions: Does HCP training enhance CGM prescription rates in a primary care setting? Does receiving a CGM prescription lead to improved Type 2 Diabetes control, as measured by Hemoglobin A1c levels? What barriers do patients face when prescribed and using CGMs? Given the significant impact of CGMs on diabetes management, this project seeks to improve CGM utilization among eligible patients through a focused intervention for HCPs and evaluate diabetes outcomes for those who do and do not receive a CGM. Methodology: HCPs and staff from three clinics within the same healthcare system will undergo a brief, in-person training on current clinical guidelines and insurance eligibility for CGMs. A booster session will follow about one month later to reinforce learning and address any prescribing challenges. Training efficacy will be evaluated by comparing CGM prescription rates before and after training using electronic health records. HCPs will complete pre- and post-training surveys to assess changes in knowledge, beliefs, and prescribing practices related to CGMs. Additionally, a small subset of prescribers will participate in interviews about their experiences with CGM prescriptions four months post-training. Patient Recruitment and Surveys: Patients with Type 2 Diabetes will be recruited for surveys at baseline, and at 3 and 6 months. These surveys will gather information on their diabetes management experience, levels of diabetes distress, and whether CGM discussions occurred with their primary care provider. Participants who received CGM prescriptions will share their experiences and any barriers encountered. A subset will also be invited for interviews to further explore their CGM experiences. Conclusion: This study seeks to fill a crucial gap in understanding how HCP training influences CGM prescription rates and the associated diabetes management outcomes, ultimately aiming to enhance diabetes care for a vulnerable population.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study aims to increase the use of continuous glucose monitors (CGMs) — small wearable devices that track blood sugar levels throughout the day — among people with Type 2 diabetes in underserved communities. Researchers will also train clinic staff on a CGM education toolkit. **You may be eligible if...** - You are 18 or older with Type 2 diabetes diagnosed at least 1 year ago - You are a current patient at one of three participating Innercare Clinics - You speak English or Spanish - You have phone access and plan to stay in the area for at least 6 months **You may NOT be eligible if...** - You have Type 1 diabetes, gestational diabetes, or diabetes insipidus - You were diagnosed with diabetes less than 1 year ago - You plan to move out of the area within 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCGM Toolkit Prescriber Training

A CGM prescription toolkit was created for prescribing clinicians and staff that includes written guidance on CGM eligibility criteria, instructions for screening patients for eligibility using EHR records and during healthcare visits, recommended provider documentation templates to address all required eligibility criteria for insurance coverage of CGM device and supplies (e.g., Medicare, Medicaid), sample scripts for communicating with patients about the purpose and use of CGM, and patient-level frequently asked questions (FAQs), including free resources available to learn more about CGM benefits, where/how to acquire CGM, and determining out-of-pocket costs. The toolkit will be introduced during a 20 minute initial training session and reinforced during a 10 minute booster training approximately one month after initial training


Locations(2)

Innercare Inc

El Centro, California, United States

Innercare, Inc

El Centro, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06638099


Related Trials